Experimental treatments based on CRISPR-Cas9 gene editing technology are at a crossroads, with...
- Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?
- James MacKenzie Q&A: How late-stage packaging customisation is shaking up the pharmaceutical supply chain
- Exscientia’s partnership spree continues with $25m Celgene deal
- Blue Brain Project clarifies neurons’ structure and role in disease
- False flags: are search engines benefiting rogue online pharmacies?
Study shows CRISPR could help treat lung disease in utero
A proof-of-concept study by Penn Medicine and Children’s Hospital of Philadelphia (CHOP) in the US has offered hope for the treatment of lung diseases before birth by using CRISPR gene editing.
Zenith Technologies Launches 24/7 Life Science Manufacturing IT Service
Zenith Technologies has launched and released a global 24/7 manufacturing IT support service specially designed to meet the support needs of the life science industry.
Gene genie: can CRISPR-Cas9 deliver on its promise to transform genome therapy?
Experimental treatments based on CRISPR-Cas9 gene editing technology are at a crossroads, with the first European trial now enrolling patients and new clinical applications and delivery methods steadily emerging. It’s not all good news though; two studies in 2018 found that a majority of patients had T-cell immunity against a type of Cas9. Sally Turner investigates at this important juncture.
Pfizer to use Concerto HealthAI technology for cancer treatments
Pfizer has partnered with patient-centred research firm Concerto HealthAI to fast-track actionable patient insights for investigational and commercialised cancer therapies.
Epigenetics: an exciting new approach in prostate cancer
The authors of a study of an epigenetic protein inhibitor concluded that ZEN-3694 shows encouraging disease stabilisation, robust target modulation and is well tolerated.
Aqueous Cleaning in Pharmaceutical Manufacturing
The use of aqueous cleaning in pharmaceutical manufacturing can provide numerous benefits in terms of effectiveness, minimal surface residue, and easier cleaning validation.
James MacKenzie Q&A: How late-stage packaging customisation is shaking up the pharmaceutical supply chain
Tablets in blisters may seem like a simple, everyday item, but in reality the manufacturing process is highly sophisticated. The trend toward smaller batch sizes and higher numbers of packaging variants is driving many manufacturers to turn to ‘postponement’ to improve the efficiency of their supply chains.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.